Affordability Check
How to afford VANRAFIA
Generic name: atrasentan
Pick how you're covered. We'll show you the cheapest legitimate way to get VANRAFIA — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About VANRAFIA and its cost
What is this medication? Braftovi is a prescription medication that belongs to a class of drugs known as kinase inhibitors. It is primarily used to treat certain types of skin cancer called melanoma that have spread to other parts of the body or cannot be removed by surgery. This medication specifically targets cancer cells that have a specific abnormal gene known as the BRAF V600E or V600K mutation. By blocking the activity of the protein produced by this mutated gene, the drug helps slow down or stop the growth and spread of the cancer cells. In addition to its use for skin cancer, Braftovi is also prescribed for the treatment of metastatic colorectal cancer in adults who have received prior therapy. For this condition, it is typically used in combination with other medications, such as cetuximab, to target the BRAF V600E mutation. Before starting treatment, healthcare providers will perform a laboratory test to confirm the presence of this specific genetic mutation. Patients should take this medication exactly as directed by their doctor and be aware of potential side effects that may require medical monitoring.
VANRAFIA is made by Pfizer Inc.. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford VANRAFIA?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for VANRAFIA?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Pfizer Inc. has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover VANRAFIA?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about VANRAFIA
Full VANRAFIA drug page
FDA label, prior authorization rules, full indications list
More options for Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3